These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 5540546

  • 1. Medullary carcinoma of the thyroid with hypercalcitoninemia and hypocalcemia.
    Markovitz M.
    Ariz Med; 1971 Jan; 28(1):26-7. PubMed ID: 5540546
    [No Abstract] [Full Text] [Related]

  • 2. Medullary carcinoma of the thyroid gland. Studies of thyrocalcitonin in plasma and tumor extracts.
    Tashjian AH, Melvin EW.
    N Engl J Med; 1968 Aug 08; 279(6):279-83. PubMed ID: 5660301
    [No Abstract] [Full Text] [Related]

  • 3. [Thyroid medullary cancer: does the hyperthyrocalcitonin syndrome exist?].
    Milhaud G, Coutris G, Tubiana M.
    Probl Actuels Endocrinol Nutr; 1969 Aug 08; 13():111-33. PubMed ID: 5404018
    [No Abstract] [Full Text] [Related]

  • 4. Discordance between plasma calcitonin and tumor-cell mass in medullary thyroid carcinoma.
    Trump DL, Mendelsohn G, Baylin SB.
    N Engl J Med; 1979 Aug 02; 301(5):253-5. PubMed ID: 449992
    [No Abstract] [Full Text] [Related]

  • 5. Immunoassay of calcitonin in rat medullary thyroid carcinoma.
    Deftos LJ, Boorman GA, Roos BA.
    Horm Metab Res; 1976 Jan 02; 8(1):83-4. PubMed ID: 1248795
    [No Abstract] [Full Text] [Related]

  • 6. Biochemical studies on four patients with medullary carcinoma of the thyroid.
    Woodhouse NJ, Gudmundsson TV, Galante L, Nadarajah A, Buckle RM, Joplin GF, MacIntyre I.
    J Endocrinol; 1969 Sep 02; 45(1):Suppl:xvi. PubMed ID: 5347398
    [No Abstract] [Full Text] [Related]

  • 7. Biochemical results of reoperations for medullary thyroid carcinoma.
    Fernandez Vila JM, Peix JL, Mandry AC, Mezzadri NA, Lifante JC.
    Laryngoscope; 2007 May 02; 117(5):886-9. PubMed ID: 17473689
    [Abstract] [Full Text] [Related]

  • 8. [Present status of calcitonin research with special attention to conditions in man].
    Sorensen OH, Hindberg I.
    Ugeskr Laeger; 1970 Feb 26; 132(9):426-9. PubMed ID: 4914424
    [No Abstract] [Full Text] [Related]

  • 9. Suppression and stimulation of calcitonin secretion in medullary thyroid carcinoma.
    Deftos LJ, Goodman AD, Engelman K, Potts JT.
    Metabolism; 1971 Apr 26; 20(4):428-31. PubMed ID: 4994451
    [No Abstract] [Full Text] [Related]

  • 10. [The role of calcitonin and parathormone in post-thyroidectomy hypocalcemia].
    Busetto E, Girelli ME, Pelizzo MR, Meduri F, Busnardo B.
    Minerva Endocrinol; 1984 Apr 26; 9(1):31-6. PubMed ID: 6503901
    [No Abstract] [Full Text] [Related]

  • 11. Abnormal intradermal histamine reaction and elevated serum calcitonin in the syndrome of: medullary carcinoma of the thyroid gland, pheochromocytoma, and multiple mucosal neuromas. A survey and a case in a child with symptoms from early childhood.
    Flensborg EW, Schiotz PO.
    Dan Med Bull; 1974 Mar 26; 21(1):20-6. PubMed ID: 4829109
    [No Abstract] [Full Text] [Related]

  • 12. Medullary carcinoma and thyrocalcitonin.
    Tubiana M, Milhaud G, Coutris G, Lacour J, Parmentier C, Bok B.
    Br Med J; 1968 Oct 12; 4(5623):87-9. PubMed ID: 5748583
    [Abstract] [Full Text] [Related]

  • 13. [Type of surgery for 147 patients with medullary carcinoma of the thyroid].
    Huang CP, Zhu YX, Tian AL.
    Zhonghua Zhong Liu Za Zhi; 2003 Sep 12; 25(5):490-2. PubMed ID: 14575577
    [Abstract] [Full Text] [Related]

  • 14. [Thyrocalcitonin and amyloid in medullary carcinoma of the thyroid].
    Fujimoto Y, Oka A, Suzuki H, Ogata E, Eto S.
    Saishin Igaku; 1970 Feb 10; 5(2):460-9. PubMed ID: 5438492
    [No Abstract] [Full Text] [Related]

  • 15. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
    Chi DD, Moley JF.
    Surg Oncol Clin N Am; 1998 Oct 10; 7(4):681-706. PubMed ID: 9735129
    [Abstract] [Full Text] [Related]

  • 16. [Effect of 25-HCC in a hypocalcemic patient with active metastases from an operated thyroid medullary tumor].
    Miravet L, Carré M, Bordier P, Hioco D, Prost A, Rambaud JC, Bernier JJ.
    Ann Endocrinol (Paris); 1972 Oct 10; 33(3):270-1. PubMed ID: 4650586
    [No Abstract] [Full Text] [Related]

  • 17. The syndrome of excessive thyrocalcitonin produced by medullary carcinoma of the thyroid.
    Melvin KE, Tashjian AH.
    Proc Natl Acad Sci U S A; 1968 Apr 10; 59(4):1216-22. PubMed ID: 5240025
    [No Abstract] [Full Text] [Related]

  • 18. [Radioimmunological determination of calcitonin in monitoring medullary carcinoma of the thyroid].
    Trucchi M, Marchisio M, Roncallo F, Schenone F, Santaniello B.
    Arch Maragliano Patol Clin; 1980 Apr 10; 36():25-30. PubMed ID: 6896418
    [No Abstract] [Full Text] [Related]

  • 19. Diagnostic applications of calcitonin immunoassay.
    Deftos LJ, Bronzert D, Parthemore JG.
    Ann Clin Lab Sci; 1974 Apr 10; 4(6):484-6. PubMed ID: 4429342
    [No Abstract] [Full Text] [Related]

  • 20. Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma.
    Guignat L, Bidart JM, Nocera M, Comoy E, Schlumberger M, Baudin E.
    Br J Cancer; 2001 Mar 23; 84(6):808-12. PubMed ID: 11259096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.